Protalix Biotherapeutics, Inc. (PLX) SEC Filings — 2025
12 SEC filings for Protalix Biotherapeutics, Inc. (PLX) in 2025.
Filings
- Protalix Narrows 9-Month Loss to $1.1M on Revenue Growth — 10-Q · Nov 13, 2025
- Protalix BioTherapeutics Files 8-K — 8-K · Nov 3, 2025
- Protalix BioTherapeutics Files 8-K — 8-K · Oct 17, 2025
- Protalix BioTherapeutics Files 8-K: Material Agreement & Exhibits — 8-K · Aug 22, 2025
- Protalix Narrows H1 Loss on Strong Revenue Growth, Q2 Turns Profit — 10-Q · Aug 14, 2025
- Protalix BioTherapeutics Files 8-K Report — 8-K · Aug 1, 2025
- Protalix BioTherapeutics Files 8-K on Key Corporate Events — 8-K · Jul 21, 2025
- Protalix BioTherapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 26, 2025
- Protalix BioTherapeutics Files Q1 2025 10-Q — 10-Q · May 9, 2025
- Protalix BioTherapeutics Files 2025 Proxy Statement — DEF 14A · Apr 30, 2025
- Protalix BioTherapeutics Files 8-K on Officer/Director Changes — 8-K · Apr 23, 2025
- Protalix BioTherapeutics Files 2024 10-K — 10-K · Mar 17, 2025